These reductions in IL-17 release and Th17 activation are associated with significantly decreased risk for HTN, HELLP syndrome, and renal dysfunction following ischemic injury (Alexander et al., 2001; Morris et al., 2016; Boesen, 2018). The gene discussed is IL17A; the disease is hypertensive disorder.